Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear
Consumption of hemp flowers in Italy went up during the nationwide COVID-19 lockdown, despite their sale being illegal in the country, a survey has revealed
A strong online presence has been essential to resiliency through the COVID-19 pandemic, but many larger offline retail chains that have also focused on selling through these channels may still see a recovery
The loss of conferences and expos due to COVID-19 prevention measures has not affected the sale of white label goods as much as may have been anticipated, according to companies
Hemp flower has become increasingly available in Spanish tobacconists (estancos) and even on corner newsstands during the COVID-19 crisis – even thought its sale is not permitted under Spanish law
Canadian grower Beleave has become the latest casualty of turbulent times in the cannabis industry
Subscription services are a niche area of the CBD market that could benefit from the ongoing COVID-19 pandemic, providing companies with security and customers with a way to try new products without leaving home
CBD companies based in Europe have a range of possible options for government assistance to help them through the various strictures imposed due to the coronavirus pandemic
UK companies that are struggling and in need of assistance because of due to lockdown rules in the face of the COVID-19 pandemic have several options to choose from, depending on their size and their needs
The US Food and Drug Administration (FDA) has published an announcement of a product recall made voluntarily by a company after tests suggested the CBD oil contained too much lead
A Canadian company part-owned by singer Bif Naked has run foul of Canada’s national health authority after suggesting its CBD products can help protect users from COVID-19
Every state in the US is offering some sort of tax relief in response to the coronavirus pandemic, and many hemp and CBD companies may be eligible for such relief
The answer is not quite clear. A lot of companies reported no drop or even increases in sales compared to the previous year. There could be several reasons for this. Firstly, all cannabinoid-related products are still part of a growing industry. Increases from a low base are not surprising and it is difficult to calculate […]
Initial reports on the results of the first ever socially distanced 4/20 are a mixed bag
The ongoing pandemic lockdown looks to be ending in some areas with easing of measures in numerous jurisdictions. But the months lost – and continued social distancing measures which will not be entirely lifted in the near future – will have an impact on regulation going forward. However official sources are unlikely to admit and […]
While the global coronavirus epidemic and consequent lockdown have caused uncertainty in the cannabis sector, investments in CBD are likely to go ahead in the coming months, some experts in the industry say
CBD businesses in the US that have seen business impacted by the coronavirus pandemic and associated social measures could be eligible for a variety of state aid programmes. Extra funding for the programmes was just approved by both the US House of Representatives and Senate, with Trump expected to sign eminently. The extra funds means the […]
As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides some analysis relating to the three main areas impacted in CBD industry: demand, supply, and regulation; however, he believes that it is too early to discuss the long-term impacts.
Further advances towards the legalisation of cannabis in Mexico have been delayed by a government shutdown due to the COVID-19 pandemic, with a new deadline for legislation set by the country’s Supreme Court
Most US hemp and CBD businesses should qualify for economic relief during the COVID-19 pandemic – but the type of assistance may vary dependent on qualification and availability of funds
CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis
Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities
Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK happen through channels that would be deemed non-essential. And while some of that trade will transition to online channels, many […]
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
Legislative measures are on hold in half the states of the US due to the COVID-19 emergency, with most suspending activity until at least mid-April
Industry organisations have responded in anger to continued claims being made by some companies about the supposed power of cannabinoids in tackling COVID-19
Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust
Expected retail closures will have a significant impact on the distribution of CBD products in most major markets, according to analysis of CBD-Intel data
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD’s reputation
A company has launched a hand sanitiser infused with CBD, a US wellness brand is selling what it claims is the world’s first CBD blanket, and Dog-sledding champion Lance Mackey has admitted to giving his dogs CBD, plus more
As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and details
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.
Free sample available
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
